NCT01904110View on ClinicalTrials.gov

To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women

PHASE4CompletedINTERVENTIONAL

Enrollment

196

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 29, 2014

Study Completion Date

March 31, 2016

Conditions

Osteoporosis

Interventions

DRUG

Risedronate/Cholecalciferol combination(montly)

once a month

DRUG

Risedronate/Cholecalciferol combination(weekly)

once a week

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT01904110 - To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women | Biotech Hunter | Biotech Hunter